Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
CADM2 Biologics Sequence Review Report 2026: Cell adhesion molecule 2 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CADM2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CALCR Biologics Sequence Review Report 2026: Calcitonin receptor Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CALCR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CADM4 Biologics Sequence Review Report 2026: Cell adhesion molecule 4 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CADM4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CADM3 Biologics Sequence Review Report 2026: Cell adhesion molecule 3 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CADM3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
C8G Biologics Sequence Review Report 2026: Complement component C8 gamma chain Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of C8G protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
C5AR2 Biologics Sequence Review Report 2026: C5a anaphylatoxin chemotactic receptor 2 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of C5AR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CADM1 Biologics Sequence Review Report 2026: Cell adhesion molecule 1 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CADM1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
C5AR1 Biologics Sequence Review Report 2026: C5a anaphylatoxin chemotactic receptor 1 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of C5AR1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
C1RL Biologics Sequence Review Report 2026: Complement C1r subcomponent-like protein Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of C1RL protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
C3AR1 Biologics Sequence Review Report 2026: C3a anaphylatoxin chemotactic receptor Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of C3AR1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
C1QL4 Biologics Sequence Review Report 2026: Complement C1q-like protein 4 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of C1QL4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
C1QL2 Biologics Sequence Review Report 2026: Complement C1q-like protein 2 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of C1QL2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
18
19
20
21
22
>>
1586
>